Obagi CLENZIderm M.D. Resurfacing Multi-Acid Peel Pad single foil sachet
Good choice for Rough Texture
What Makes This Different

Where most at-home peel pads pick one or two acids and hide the strengths, these declare four, 4% glycolic, 3% phytic, 2% salicylic and 1% mandelic, chosen to work at different depths and solubilities, and put niacinamide seventh to calm what they stir up. The dual-textured pad and the single-use sachets are the clinical-brand touches; the alcohol, menthol and musk are the CLENZIderm habits the formula could have lost.

Obagi

Obagi Resurfacing Multi-Acid Peel Pads Review

Four-Acid Clinical Peel Pad
exfoliant pad clinical Paraben Free Fungal Acne Safe Vegan Not Cruelty Free

A well-reasoned four-acid pad, every strength disclosed, niacinamide placed to calm it, single sachets to keep it fresh, and a real if brand-run eight-week study. For oily, congested, resilient skin it resurfaces and clears on schedule. It also carries denatured alcohol, menthol and a musk fragrance that a leave-on acid did not need, it is new enough that its tolerability record is thin, and $100 for thirty pads is a physician-brand price.

$100.00
30 pads
4.7 ★★★★★
25 reviews
Made in United States Launched 2026 All-year use PAO: 12 months
Buy at Amazon ♥
Run it through our tools Clashes with my routine? Pregnancy-safe? Find a cheaper dupe Patch-test it first

These pads launched in August 2026 and have only a few dozen reviews, so this assessment rests on the disclosed acid percentages, the independent literature for each acid and Obagi's eight-week brand study, which reports participant-agreement figures and has not published its sample size. Tolerability across skin types beyond the oily, resilient target is not yet well documented.

Verdicts

How well it fits each concern

Verdict by concern tap a concern for the case

Good choicefor Rough TextureGlycolic Acid is a reference standard by mechanism for rough texture; this pad carries it at 4%.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Glycolic Acid 4% has trial-supported standing for this concern.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. As of September 25, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active
Glycolic Acid 4%
Standing
supported — its mechanism is established
Form
adequate (declared 4%) — studied range 4–10%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability
standard
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

  • International Cosmetic Ingredient Dictionary and Handbook — declared function — Personal Care Products Council
  • Harry's Cosmeticology / Baran & Maibach Textbook of Cosmetic Dermatology — humectant, emollient and occlusive classification — standard reference text
All rough texture products →
Strong choicefor AcneSalicylic Acid is an approved or monograph active for acne; this pad carries it at 2%.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Salicylic Acid 2% is a first-line active — approved, monograph-listed or named in current guidelines — for this concern.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Cautions: known irritants.

Same rule for everyone. “Strong choice” is the verdict on 1,459 of 45,024 concern verdicts across the catalog; rule R2 decided 892 of them. As of September 25, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R2 — A regulator- or guideline-recognised first-line active, declared at an effective strength, in a form the claim supports. · the full register
Carrying active
Salicylic Acid 2%
Standing
first line — a regulator recognises it for this use; trials support it · per § 333.310 Acne active ingredients. (U.S. Food and Drug Administration — 21 CFR Part 333 Subpart D (Topical Acne Drug Products), Code of Federal Regulations via GovInfo), opened July 27, 2026
Form
adequate (declared 2%) — studied range 0.5–2%, from the OTC monograph or label; judge it after ~6 weeks
Tolerability
standard — irritant load
Row checked
against its sources on July 27, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All acne products →
Strong choicefor BlackheadsSalicylic Acid is an approved or monograph active for blackheads; this pad carries it at 2%.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Salicylic Acid 2% is a first-line active — approved, monograph-listed or named in current guidelines — for this concern.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Same rule for everyone. “Strong choice” is the verdict on 1,459 of 45,024 concern verdicts across the catalog; rule R2 decided 892 of them. As of September 25, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R2 — A regulator- or guideline-recognised first-line active, declared at an effective strength, in a form the claim supports. · the full register
Carrying active
Salicylic Acid 2%
Standing
first line — a regulator recognises it for this use; trials support it · per 21 CFR § 333.350 - Labeling of acne drug products. (US Code of Federal Regulations (Legal Information Institute, Cornell Law School)), opened July 27, 2026
Form
adequate (declared 2%) — studied range 0.5–2%, from the OTC monograph or label; judge it after ~6 weeks
Tolerability
standard
Row checked
against its sources on July 27, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All blackheads products →
Promisingfor Large PoresNiacinamide has trial-level evidence for large pores but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Niacinamide has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. As of September 25, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Niacinamide
Standing
plausible — trials support it
Form
plausible — studied range 4%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability
standard
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All large pores products →
Good choicefor DullnessGlycolic Acid is a reference standard by mechanism for dullness; this pad carries it at 4%.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Glycolic Acid 4% has trial-supported standing for this concern.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. As of September 25, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active
Glycolic Acid 4%
Standing
supported — its mechanism is established
Form
adequate (declared 4%) — studied range 4–10%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability
standard
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

  • Harry's Cosmeticology / Baran & Maibach Textbook of Cosmetic Dermatology — humectant, emollient and occlusive classification — standard reference text
All dullness products →
Good choicefor HyperpigmentationNiacinamide is a trial-supported active for hyperpigmentation; this pad carries it, though the concentration is not declared.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Niacinamide has trial-supported standing for this concern.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Cautions: known irritants; a photosensitising active — use sun protection.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. As of September 25, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active
Niacinamide
Standing
supported — trials support it
Form
plausible — studied range 2–5%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability
standard — irritant load, photosensitization
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All hyperpigmentation products →
Promisingfor Dark SpotsNiacinamide has trial-level evidence for dark spots but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Niacinamide has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Cautions: a photosensitising active — use sun protection.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. As of September 25, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Niacinamide
Standing
plausible — trials support it
Form
plausible
Tolerability
standard — photosensitization
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All dark spots products →

A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide

Assessment

Pros & Cons

Pros

  • ✓ All four acid percentages disclosed: 4% glycolic, 3% phytic, 2% salicylic, 1% mandelic
  • ✓ Acids chosen to work at different depths and solubilities, from pore to surface to pigment
  • ✓ Niacinamide seventh in the list to calm redness and support the barrier
  • ✓ Single-use foil sachets keep the acids and alcohol from weakening in an open jar
  • ✓ Dual-textured lyocell pad lets the user choose gentle or buffing contact
  • ✓ Smoother skin by the next morning and clearer pores within weeks
  • ✓ Eight-week brand study with breakout and post-blemish-mark endpoints

Cons

  • ✗ Alcohol denat. second in the list dries and stings in a leave-on acid
  • ✗ Menthol and a synthetic musk fragrance add irritation without benefit
  • ✗ Too harsh for dry, sensitive, rosacea-prone or barrier-compromised skin
  • ✗ $100 for thirty pads is a physician-brand premium
  • ✗ Brand study has no published participant count; launched August 2026 with thin real-world data
  • ✗ Cannot share a night with retinoids, benzoyl peroxide or vitamin C
Review

Full Review

Four, three, two, one. Obagi prints the acid percentages on the box of its new peel pads, 4% glycolic, 3% phytic, 2% salicylic, 1% mandelic, and for a brand that sold its previous at-home peel for years without stating a single strength, that is the most important thing about them. The Revivify Multi-Acid Facial Peel, a prep-and-peel kit that has been slipping out of retailers through 2026, asked you to trust the name. The Resurfacing Multi-Acid Peel Pads, launched in August 2026 under the CLENZIderm M.D. banner, tell you what you are putting on your face, and that changes how the product can be judged.

The four-acid logic holds up. Glycolic at 4% is the small, fast, water-soluble acid doing the visible surface work, loosening the compacted cells so skin is smoother by morning. Salicylic at 2%, the monograph maximum, is oil-soluble and follows sebum into the pore, which is the comedolytic inheritance from the CLENZIderm system and the reason these pads are aimed at congestion and breakouts as much as texture. Phytic at 3% is the gentle chelating acid Obagi has used in Nu-Derm for decades, binding the metal ions behind oxidative pigment and mildly inhibiting tyrosinase, and mandelic at 1% is the large, slow AHA with a record in darker skin where glycolic alone can provoke marks. All four are partly neutralised with sodium hydroxide, and niacinamide sits seventh, directly ahead of the salicylic acid, to calm redness, support the barrier the acids thin and add its own slow tone work. Willow bark extract and glycerin follow. It is a considered formula, broader than a single-acid pad and more honest about its doses than most of the category.

The pad itself is a lyocell disc, smooth on one side and lightly ridged on the other, sealed in a foil sachet so the acids and the alcohol do not evaporate or weaken over the weeks a jar of pads would sit open. Wipe it over cleansed, dry skin in the evening, avoid the eyes, do not rinse, and follow with an oil-free moisturizer once it has dried. The sensation is a tingle for a minute with a cool menthol edge, a sharper sting on any open spot, a little pinkness for half an hour, and then, by morning, skin that is noticeably smoother. Over two to four weeks pores look cleaner and congestion loosens; Obagi's eight-week study reported most participants seeing smoother texture at four weeks and, at eight, fewer breakouts, brighter tone and faded post-blemish marks. The study is the brand's own and it has not published the participant count, so the percentages are perception data rather than proof, but the effects they describe are what four acids at these strengths would be expected to produce on the right skin.

The right skin is the qualifier. Alcohol denat. is second in the list, menthol is present, and ethylene brassylate, a synthetic musk, adds fragrance to a product that will sit on the face all night. On oily, resilient, congestion-prone skin those are tolerable and the alcohol is arguably useful, carrying the acids and drying to a matte finish. On combination, normal, dry or sensitive skin they are three unnecessary irritants layered on top of four acids, and they are the reason the early complaints, stinging, dryness and flaking in the first weeks, cluster among users who were not the target. A clinical brand launching a new leave-on acid in 2026 could have dropped all three; that it kept them is the CLENZIderm line's oldest habit.

Because the pads are new, the honest caveat is that their real-world tolerability record is a few dozen reviews long. The acids are well known; the combination, the pad and the alcohol base are not yet proven across the range of skin that will buy them. Obagi's own guidance, two or three nights a week as tolerated, is the right pace, and starting at two is where most people should stay for the first fortnight.

The two-sided pad deserves a word, because it is the most useful design detail and the easiest to misuse. The smooth side deposits the solution with almost no friction and is what most faces should use for most passes; the ridged side adds a physical buff that, on rough or congested patches, helps the acids reach compacted cells, and that, dragged across the whole face on the third night of the week, is how people end up with a raw jawline. The pad gives you the choice; the discipline is yours.

On price, $100 for thirty pads is about $3.30 a treatment and lasts ten to fifteen weeks at the recommended frequency, which is $25 to $40 a month. That is a physician-brand premium over drugstore peel pads that disclose one or two acids, and a reasonable price against clinical-brand pads that disclose nothing. The value case rests on the four-acid design and the transparency; the alcohol, menthol and musk are the parts you pay for and would rather not.

For oily, combination or normal skin with congestion, uneven texture and lingering post-acne marks, and the resilience to take a four-acid pad two or three nights a week, this is a well-built, well-labelled option that should deliver what its box says. For sensitive, dry, rosacea-prone or barrier-compromised faces, the alcohol and fragrance settle the question before the acids do, and a gentler polyhydroxy or mandelic product will resurface without the sting.

Formula

Key Ingredients

The hero actives that drive this product's performance.

IngredientFunctionEvidence
Glycolic Acid 4% (4%) The lead acid at a declared 4%, third in the list and partly neutralised by the sodium hydroxide, doing the surface work: loosening the compacted outer cells so the pad leaves skin smoother by the next morning. At this level in a leave-on pad used two or three nights a week it resurfaces steadily rather than peeling. Established mechanism for Rough Texture · established mechanism
Salicylic Acid 2% (2%) The oil-soluble acid at the monograph maximum, eighth in the list, reaching into pores the water-soluble acids cannot; it is the CLENZIderm inheritance in the formula and the reason the pads are pitched at congested, breakout-prone skin rather than only at texture. Established mechanism for Rough Texture · established mechanism
Phytic Acid 3% (3%) A chelating plant acid at 3%, fourth in the list, that exfoliates gently, binds the metal ions that drive oxidative pigment and mildly inhibits tyrosinase, which is where the pads' brightening and post-blemish-mark claims come from; Obagi has used it as its sensitive-skin acid in Nu-Derm for decades. Not yet assessed
Mandelic Acid 1% (1%) The largest and slowest AHA at a modest 1%, adding lipophilic exfoliation and a track record in darker skin tones where glycolic alone can provoke pigment; it rounds out a four-acid blend that works at different depths and speeds. Limited for Acne
Niacinamide Seventh in the list, directly ahead of the salicylic acid, niacinamide is the counterweight: it calms the redness four acids can raise, supports the barrier lipids they thin, and adds its own tone-evening work to the phytic acid's, which is why the pads claim clarity as well as resurfacing. Emerging for Hyperpigmentation
Full INCI List

Aqua (Water), Alcohol Denat., Glycolic Acid, Phytic Acid, Ethoxydiglycol, Sodium Hydroxide, Niacinamide, Salicylic Acid, Mandelic Acid, Salix Alba (Willow) Bark Extract, Glycerin, Menthol, Ethylene Brassylate, Phenoxyethanol

Safety & Formulation Facts
? Pregnancy Safety Unverified ✗ Fragrance Free✗ Alcohol Free✓ Oil Free✓ Silicone Free✓ Paraben Free✓ Sulfate Free✗ Cruelty Free✓ Vegan✓ Fungal Acne Safe
Potential Irritants
Glycolic AcidSalicylic AcidAlcohol Denat.MentholEthylene Brassylate
Common Allergens
Ethylene BrassylateSalix Alba (Willow) Bark Extract
Compatibility

Skin Match

Best For
Works For
Not Ideal For
Routine Step

treatment

Time of Day

PM

Layering Tips

Wipe one pad over cleansed, dry skin in the evening, two or three nights a week, avoiding the eyes; do not rinse, and follow with an oil-free moisturizer once it has dried. Keep retinoids and benzoyl peroxide for the other nights, and wear sunscreen every morning.

Results Timeline

A tingle on the night and smoother skin by the next morning after the first use. Obagi's study reported visibly smoother texture at four weeks and, at eight, smoother skin, fewer breakouts and brighter tone with faded post-blemish marks; the pigment work of phytic and mandelic acids is the slowest part and needs the full eight to twelve weeks.

Pairs Well With
niacinamideceramidesoil-free-moisturizersunscreen
Planning a combo? Check it against what you already use
Conflicts With
tretinoinretinolretinalbenzoyl-peroxidevitamin-c
See where it fits — layering order & night-splitting
Sample AM Routine
  1. Gentle cleanser
  2. Niacinamide serum
  3. Oil-free moisturizer
  4. Broad-spectrum SPF 50
Sample PM Routine
  1. Gentle cleanser
  2. THIS PRODUCT (2-3 nights a week)
  3. Oil-free moisturizer
Evidence

Science & Expert Perspective

The Science

The pads combine four acids that the exfoliation literature characterises separately, and the rationale for stacking them is that each works at a different depth and solubility. Glycolic acid, the smallest alpha-hydroxy acid, penetrates fastest and reduces corneocyte cohesion in the lower stratum corneum; a 2013 review in Clinical, Cosmetic and Investigational Dermatology summarised its use across acne, scarring, melasma, post-inflammatory hyperpigmentation and photoaging, noting that depth of effect scales with concentration, contact time and pH and that it is safe in Fitzpatrick types I to IV. At a declared 4%, partly neutralised, in a leave-on pad used two or three nights a week, it acts as a steady resurfacer rather than a peel. Salicylic acid at 2% is lipophilic and desmolytic, disrupting the junctions between corneocytes inside the sebum-filled follicle, which is the basis of its comedolytic action and its place in acne care. Phytic and mandelic acids are the gentler, slower members: phytic acid chelates metal ions and mildly inhibits tyrosinase, and mandelic acid, a large lipophilic AHA, penetrates slowly and is favoured in darker skin. Comparative peel work in melasma has found phytic acid combinations less effective than glycolic or salicylic-mandelic peels at professional strengths, which is consistent with their supporting rather than leading role here.

Niacinamide, seventh in the list ahead of the salicylic acid, addresses the two costs of a four-acid leave-on: it reduces inflammatory signalling and stimulates barrier lipid synthesis, and it inhibits melanosome transfer, contributing to the post-blemish-mark claim alongside the phytic and mandelic acids. Willow bark extract supplies salicylates and polyphenols in a minor role, and glycerin provides modest humectancy. The vehicle is a denatured-alcohol-and-water solution with ethoxydiglycol as a penetration enhancer, which improves delivery of the acids and dries to a matte finish at the cost of barrier dryness, and menthol and ethylene brassylate, a synthetic musk, are sensory additions without therapeutic effect. Sodium hydroxide partly neutralises the acids to a leave-on pH. Obagi's eight-week clinical study, reporting visibly smoother texture at four weeks and, at eight, smoother skin, improved breakouts and brighter tone with reduced post-blemish marks, is brand data with participant-agreement endpoints and an undisclosed sample size, and should be read as consistent with the acids' known effects rather than as independent confirmation.

Dermatologist Perspective

Multi-acid leave-on pads at modest, disclosed strengths occupy a reasonable place in clinical advice for oily, congested or textured skin, typically as a two-or-three-nights-a-week step alternating with a retinoid or benzoyl peroxide, and the combination of glycolic and salicylic acids for surface and pore with phytic and mandelic acids for gentler, pigment-oriented work is a coherent design that practitioners would recognise as more thoughtful than the single-acid pads that dominate the category. Transparency about percentages is welcomed because it lets a clinician predict tolerance and advise on frequency. The reservations are about the vehicle: denatured alcohol, menthol and fragrance in a product left on overnight are avoidable irritants that increase barrier disruption and, in darker skin, the risk of post-inflammatory pigmentation that the phytic and mandelic acids are meant to address, so dermatologists would generally restrict the pads to resilient oily skin and steer sensitive, rosacea-prone, eczema-prone or melasma patients toward alcohol-free alternatives. As a new product with only a brand study behind it, expectations would be set on the known behaviour of the acids rather than on the marketing figures, with the usual instructions on sunscreen, spacing from other actives and pausing on irritated skin.

Guidance

Usage & Recommendations

How to Use

Use in the evening, two or three nights a week, on cleansed and thoroughly dry skin. Tear open one sachet, unfold the pad and wipe it over the face in gentle strokes, using the smooth side for a light pass and the ridged side only on rough or congested areas, and avoiding the eye contour, lips and any open or inflamed spots. Do not rinse; let the solution dry for a minute, then apply an oil-free moisturizer. Begin with two nights a week, spaced apart, for the first two weeks and add a third only if there is no lingering tightness, flaking or redness; if there is, drop back or pause. Keep retinoids, benzoyl peroxide and vitamin C for the other nights, and do not combine the pads with any other exfoliant. Wear broad-spectrum sunscreen every morning while using them and for a week after stopping. Discard the pad after one use and keep unopened sachets away from heat.

Value Assessment

One hundred dollars for thirty pads is roughly $3.30 per treatment, and at Obagi's two or three nights a week the box lasts ten to fifteen weeks, so the running cost is $25 to $40 a month. That is a premium over drugstore peel pads with one or two disclosed acids and roughly level with other clinical-brand pads, most of which disclose less. What the money buys is a four-acid formula with every strength stated, niacinamide placed to soften it, sealed single sachets and Obagi's physician channel; what it does not buy is a gentler vehicle, since the alcohol, menthol and musk are the cheap part of the formula and the part that limits who can use it. It is also $75 cheaper than the Revivify kit it replaces while offering more than seven times the treatments. For oily, resilient skin already spending on a clinical acne routine, the value is fair; for anyone who needs to skip pads to stay comfortable, the per-treatment maths worsens quickly.

Who Should Buy

People with oily, combination or normal skin that is congested, rough or marked by post-acne pigment, who want a disclosed-strength multi-acid pad to use two or three nights a week alongside a retinoid or benzoyl peroxide routine, and who tolerate alcohol-based leave-ons without trouble. CLENZIderm system users and former Revivify buyers are the natural audience.

Who Should Skip

Skin that is dry, reactive, rosacea-prone or eczema-prone, or a barrier that is already compromised, should avoid a four-acid pad in an alcohol, menthol and fragrance base, and melasma or easily pigmenting skin should be cautious about the irritation. Anyone pregnant should ask a doctor before a leave-on salicylic product, and anyone who cannot commit to sunscreen every morning should not use acids at night.

Ready to try Obagi Resurfacing Multi-Acid Peel Pads?

Buy at Amazon ♥

Or visit the Obagi store on Amazon →

Details

Product Details

Texture

A dual-textured lyocell pad, smooth on one side and lightly ridged on the other, soaked in a thin alcohol-water solution that spreads cool and evaporates within a minute to a dry, matte finish

Scent

A sharp menthol-and-alcohol note over a soft musky perfume, noticeable for a minute or two

Packaging

Thirty individually sealed foil sachets in a box, each holding one pre-soaked pad

Finish
matteinvisible
What to Expect on First Use

The first pad tingles for a minute, with a cool menthol edge and a sharper sting on any open spot, and the skin looks slightly pink for half an hour. By morning it feels noticeably smoother. Some tightness or light flaking in the first two weeks is normal at this acid load, and the two-nights-a-week start Obagi suggests is sensible; jumping to three nights at once is how most early complaints happen.

How Long It Lasts

About ten to fifteen weeks at two or three pads a week

Period After Opening

12 months

Opened yours? Track the toss-by date
Best Season

All Year

Background

The Story Behind This Product

Obagi's at-home peel history runs from the professional Blue Peel to the Revivify Multi-Acid Facial Peel kit, a four-treatment prep-and-peel set that has been quietly disappearing from retailers through 2026. The Resurfacing Multi-Acid Peel Pads launched in August 2026 as its successor under the CLENZIderm M.D. banner, trading the two-step kit for thirty single pads, adding phytic and mandelic acids and niacinamide, and publishing the percentages the old kit never did.

About Obagi Legacy Brand (20+ years)

Obagi has been a physician-dispensed brand since dermatologist Zein Obagi founded it in 1988, and the CLENZIderm M.D. line has been its acne system for nearly two decades. These pads launched in August 2026 with disclosed acid percentages and an eight-week brand clinical study whose participant count Obagi has not published; the four acids each have independent literature.

Brand founded: 1988 · Product launched: 2026
Myth vs. Reality

Common Myths

Myth

Four acids means four times the exfoliation.

Reality

The acids are chosen for different jobs at different depths: glycolic and salicylic for surface and pore, phytic and mandelic for gentle turnover and pigment, all at modest declared strengths and partly neutralised. The total effect is broader than a single acid, not four times stronger, and the pads are still meant for two or three nights a week.

Myth

Peel pads are a substitute for a professional peel.

Reality

In-office peels use unneutralised acids at 20 to 70% for minutes and are washed off. These pads leave a low-strength, buffered blend on the skin overnight and work through gradual resurfacing over weeks. They maintain and refine; they do not do what a supervised peel does in one sitting.

FAQ

Frequently Asked Questions

How often should I use Obagi Resurfacing Multi-Acid Peel Pads?

Two or three evenings a week on cleansed, dry skin, or less if the skin stings or flakes; Obagi's directions say as tolerated. Start with two nights, spaced apart, and only add a third once the first two weeks have passed without persistent tightness. Do not rinse.

What acids are in the Obagi peel pads and how strong are they?

Four, all disclosed: 4% glycolic, 3% phytic, 2% salicylic and 1% mandelic, partly neutralised with sodium hydroxide, plus niacinamide and willow bark extract. That is a moderate total acid load designed for repeated use, well below professional peel strengths.

Can I use Obagi peel pads with tretinoin or benzoyl peroxide?

Not on the same night. Use the pads on two or three evenings and the retinoid or benzoyl peroxide on the others, and expect to reduce the pads if the combination dries the skin. Stacking them will over-exfoliate.

Are Obagi peel pads suitable for sensitive skin?

Not really. Four acids in a denatured-alcohol base with menthol and a musk fragrance is a lot for reactive skin, and Obagi pitches the pads at oily, congested and blemish-prone faces. Sensitive users wanting gentle resurfacing would do better with a polyhydroxy acid product.

Do Obagi peel pads help with dark spots and post-acne marks?

That is part of the design: phytic acid chelates and mildly inhibits tyrosinase, mandelic acid has a record in pigment-prone skin, and niacinamide slows pigment transfer. Obagi's study reported reduced post-blemish marks at eight weeks; expect it to be the slowest of the pads' effects.

How are the peel pads different from Obagi's Revivify Multi-Acid Facial Peel?

Revivify was a four-treatment kit with a prep pad and a peel pad per session, built on kojic, salicylic, lactic and glycolic acids with undisclosed strengths, and it has been disappearing from retailers. The pads are thirty single-step treatments with four declared acids, niacinamide added and kojic acid dropped, sold at $100 rather than $175.

Are Obagi peel pads safe during pregnancy?

They contain 2% salicylic acid in a leave-on along with three other acids, and many obstetricians advise limiting leave-on salicylic products in pregnancy. Ask your doctor before using them while pregnant or breastfeeding.

Reviews

What Reviewers Tend to Say

Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.

Common Praise

Smoother skin the morning after the first pad

Pores and congestion clear within a few weeks

Convenient, no-rinse, no measuring

Dual-textured pad lets you choose how much to buff

Common Complaints

Stings and dries in the first weeks

Alcohol and menthol in a leave-on acid

Fragrance

$100 for 30 pads is steep

Notable Endorsements
Launched by Obagi Medical in August 2026 with disclosed acid percentagesSold through dermatology practices, Amazon and LovelySkin as the exfoliating step of the CLENZIderm M.D. line
Related Conditions
rough textureacneblackheadslarge poresdullnesshyperpigmentationdark spots
Related Ingredients
glycolic acidsalicylic acidphytic acidmandelic acidniacinamide